IRIS Institutional Research Information System - OPENBS Open Archive UniBS

PRESTA, MARCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 18.971
EU - Europa 10.506
AS - Asia 5.330
AF - Africa 35
SA - Sud America 31
OC - Oceania 22
Continente sconosciuto - Info sul continente non disponibili 20
Totale 34.915
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 18.911
PL - Polonia 3.885
CN - Cina 2.728
UA - Ucraina 2.067
DE - Germania 1.265
SG - Singapore 1.033
IT - Italia 979
HK - Hong Kong 658
FI - Finlandia 582
GB - Regno Unito 462
IE - Irlanda 363
RU - Federazione Russa 351
TR - Turchia 337
IN - India 204
VN - Vietnam 190
FR - Francia 189
CZ - Repubblica Ceca 93
SE - Svezia 77
ID - Indonesia 62
ES - Italia 59
CA - Canada 46
BE - Belgio 40
IR - Iran 34
NL - Olanda 32
AU - Australia 19
EU - Europa 19
MU - Mauritius 16
JP - Giappone 13
KR - Corea 11
MA - Marocco 11
CH - Svizzera 8
CL - Cile 8
PH - Filippine 8
CU - Cuba 7
RO - Romania 7
TW - Taiwan 7
AR - Argentina 6
LT - Lituania 6
PE - Perù 6
BR - Brasile 5
IL - Israele 5
AZ - Azerbaigian 4
BD - Bangladesh 4
BO - Bolivia 4
GE - Georgia 4
GR - Grecia 4
LK - Sri Lanka 4
NO - Norvegia 4
PK - Pakistan 4
SA - Arabia Saudita 4
SK - Slovacchia (Repubblica Slovacca) 4
BG - Bulgaria 3
DK - Danimarca 3
EG - Egitto 3
HU - Ungheria 3
KG - Kirghizistan 3
KZ - Kazakistan 3
LV - Lettonia 3
MX - Messico 3
NZ - Nuova Zelanda 3
PT - Portogallo 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
AT - Austria 2
EE - Estonia 2
HR - Croazia 2
MY - Malesia 2
PA - Panama 2
ZA - Sudafrica 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BY - Bielorussia 1
CO - Colombia 1
DO - Repubblica Dominicana 1
EC - Ecuador 1
IQ - Iraq 1
IS - Islanda 1
JM - Giamaica 1
JO - Giordania 1
KE - Kenya 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LU - Lussemburgo 1
MD - Moldavia 1
SC - Seychelles 1
SL - Sierra Leone 1
SM - San Marino 1
TH - Thailandia 1
Totale 34.915
Salva come PNG Salva come JPEG
Città #
Warsaw 3.883
Fairfield 3.026
Woodbridge 2.187
Jacksonville 1.579
Houston 1.481
Ashburn 1.469
Ann Arbor 1.179
Cambridge 1.173
Seattle 1.076
Wilmington 1.059
Singapore 849
Chandler 797
Princeton 669
Hong Kong 650
Nanjing 579
Beijing 482
Brescia 369
Dublin 359
Dearborn 336
Helsinki 304
New York 303
Istanbul 294
Dong Ket 181
Nanchang 180
Moscow 159
Shenyang 147
Des Moines 144
Hebei 144
Jinan 142
San Diego 130
Changsha 128
Shanghai 121
Jiaxing 101
Lancaster 100
Milan 98
Tianjin 93
Munich 83
Boardman 77
Los Angeles 75
Kunming 73
London 66
Brno 64
San Mateo 61
Hangzhou 60
Jakarta 59
Madrid 54
San Francisco 53
Haikou 48
Verona 48
Ningbo 43
Rome 42
Augusta 40
Lanzhou 39
Zhengzhou 38
Kocaeli 35
Brussels 34
Leawood 33
Phoenix 32
Guangzhou 31
Washington 31
Toronto 30
Taizhou 28
Fuzhou 26
Kilburn 25
Ardabil 24
Norwalk 24
Olomouc 24
Changchun 23
Monmouth Junction 23
Hefei 21
Taiyuan 19
Redwood City 18
Santa Clara 15
Nürnberg 14
Orange 14
Padova 13
Amsterdam 12
Falkenstein 12
Napoli 11
Pune 11
Gunzenhausen 10
Tokyo 10
Chicago 9
Falls Church 9
Ottawa 9
Wandsworth 8
Chiswick 7
Indiana 7
Ivry-sur-seine 7
La Habana 7
Melbourne 7
Pavia 7
Romola 7
Southwark 7
Wuhan 7
Boston 6
Canberra 6
Dronten 6
Frankfurt am Main 6
Markham 6
Totale 27.725
Salva come PNG Salva come JPEG
Nome #
U94 of human herpesvirus 6 down-modulates Src, promotes a partial mesenchymal-to-epithelial transition and inhibits tumor cell growth, invasion and metastasis 288
Brain angioarchitecture and intussusceptive microvascular growth in a murine model of Krabbe disease 276
Fibroblast growth factor/fibroblast growth factor receptor system in angiogenesis. 251
The nanostructured secretome 248
The broad-spectrum anti-DNA virus agent cidofovir inhibits lung metastasis of virus-independent, FGF2-driven tumors. 242
Bone morphogenic protein antagonist Drm/gremlin is a novel proangiogenic factor. 239
The COOH-Terminal Peptide of Platelet Factor-4 Variant (CXCL4L1/PF-4var47-70) Strongly Inhibits Angiogenesis and Suppresses B16 Melanoma Growth In vivo. 238
alphavbeta3 Integrin-dependent antiangiogenic activity of resveratrol stereoisomers. 235
Claudin3 is localized outside the tight junctions in human carcinomas 234
Fibroblast growth factor modulates mast cell recruitment in a murine model of prostate cancer 233
Ruolo dell’eparina e dei proteoglicani eparan solfati nella modulazione dell’angiogenesi indotta dal fattore di crescita basico dei fibroblasti 231
Nanoliter contact angle probes tumor angiogenic ligand-receptor protein interactions 231
β3 Integrin promotes long-lasting activation and polarization of vascular endothelial growth factor receptor 2 by immobilized ligand 231
A long pentraxin-3-derived pentapeptide for the therapy of FGF8b-driven steroid hormone-regulated cancers 230
Synthesis, Structural Elucidation, and Biological Evaluation of NSC12, an Orally Available Fibroblast Growth Factor (FGF) Ligand Trap for the Treatment of FGF-Dependent Lung Tumors 230
Antiangiogenic activity of semisynthetic biotechnological heparins: low-molecular-weight-sulfated Escherichia coli K5 polysaccharide derivatives as fibroblast growth factor antagonists. 229
Cutting edge: extracellular high mobility group box-1 protein is a proangiogenic cytokine. 228
Blocking the FGF/FGFR system as a "two-compartment" antiangiogenic/antitumor approach in cancer therapy. 226
Gremlin is a novel agonist of the major pro-angiogenic receptor VEGFR2 222
Long Pentraxin-3 inhibits FGF-dependent angiogenesis andgrowth of steroid hormone-regulated tumors 221
Matrigel plug assay: evaluation of the angiogenic response by reverse transcription-quantitative PCR 221
Monomeric gremlin is a novel vascular endothelial growth factor receptor-2 antagonist 218
Heparan Sulfate Proteoglycans Mediate the Angiogenic Activity of the Vascular Endothelial Growth Factor Receptor-2 Agonist Gremlin. 217
Angiopoietin-1 mediates the pro-angiogenic activity of the bone morphogenic protein antagonist Drm 216
Interaction of fibroblast growth factor-2 (FGF-2) with free gangliosides: biochemical characterization and biological consequences in endothelial cell cultures. 215
Sphingosine-1-phosphate receptor-1 controls venous endothelial barrier integrity in zebrafish. 212
Chemically sulfated Escherichia coli K5 polysaccharide derivatives as extracellular HIV-1 Tat protein antagonists. 211
Role of the soluble pattern recognition receptor PTX3 in vascular biology. 207
Mammalian tumor xenografts induce neovascularization in zebrafish embryos. 206
Angiogenic growth factors interactome and drug discovery: The contribution of surface plasmon resonance 206
Anti-angiogenic activity of the flavonoid precursor 4-hydroxychalcone. 205
Fibroblast growth factor 2-antagonist activity of a long-pentraxin 3-derived antiangiogenic pentapeptide. 204
TR-644 a novel potent tubulin binding agent induces impairment of endothelial cells function and inhibits angiogenesis. 202
Modulation of angiogenesis by a tetrameric tripeptide that antagonizes vascular endothelial growth factor receptor 1 200
The pattern recognition receptor PTX3 as an angiostatic epithelial/stromal FGF-targeting inhibitor in hormonal cancers 195
Fibroblast growth factors/fibroblast growth factor receptors as targets for the development of anti-angiogenesis strategies. 185
Zebrafish disease models in hematology: Highlights on biological and translational impact 175
Involvement of α(v)β (3) integrin in gremlin-induced angiogenesis. 172
Integrin {alpha}V{beta}3 as a Target for Blocking HIV-1 Tat-Induced Endothelial Cell Activation In Vitro and Angiogenesis In Vivo. 168
Long Pentraxin 3/TSG-6 Interaction: A Biological Rheostat for Fibroblast Growth Factor 2–Mediated Angiogenesis 166
Biological activity of substrate-bound basic fibroblast growth factor (FGF2): recruitment of FGF receptor-1 in endothelial cell adhesion contacts. 165
Cyclic adenosine monophosphate-response element-binding protein mediates the proangiogenic or proinflammatory activity of gremlin. 163
Long pentraxin-3 follows and modulates bladder cancer progression 163
Basic fibroblast growth factor in neuronal cultures of human fetal brain. 162
Fibroblast growth factor receptor-1 phosphorylation requirement for cardiomyocyte differentiation in murine embryonic stem cells. 159
Anti-FGF2 approaches as a strategy to compensate resistance to anti-VEGF therapy: long-pentraxin 3 as a novel antiangiogenic FGF2-antagonist. 158
The potential of fibroblast growth factor/fibroblast growth factor receptor signaling as a therapeutic target in tumor angiogenesis. 156
ANTI-ANGIOGENIC ACTIVITY OF A NEUTRALIZING HUMAN SINGLE-CHAIN ANTIBODY FRAGMENT AGAINST FIBROBLAST GROWTH FACTOR RECEPTOR 1 155
A Pro-inflammatory Signature Mediates FGF2-induced Angiogenesis 153
The zebrafish/tumor xenograft angiogenesis assay. 152
Anti-angiogenic activity of the purine analog 6-thioguanine. 152
Fibroblast growth factor-2 antagonist and Antiangiogenic activity of long-pentraxin 3-derived synthetic peptides 151
Basic fibroblast growth factor is released from endothelial extracellular matrix in a biologically active form. 147
Biologically active synthetic fragments of human basic fibroblast growth factor (bFGF): identification of two Asp-Gly-Arg-containing domains involved in the mitogenic activity of bFGF in endothelial cells. 147
CEACAM1/VEGF cross-talk during neuroblastic tumour differentiation 144
Long Pentraxin-3 As An Epithelial-Stromal Fibroblast Growth Factor-Targeting Inhibitor In Prostate Cancer. 144
A tool for the quantification of radial neo-vessels in chick chorioallantoic membrane angiogenic assays 143
Paracrine and autocrine effects of fibroblast growth factor-4 in endothelial cells. 142
Critical role of gonadal hormones on the genotoxic activity of the hepatocarcinogen DL-ZAMI 1305. 142
The thymidine phosphorylase inhibitor 5'-O-tritylinosine (KIN59) is an anti-angiogenic multi-target fibroblast growth factor-2 antagonist. 140
Shedding of membrane vesicles mediates fibroblast growth factor-2 release from cells. 135
Gene expression profile in fibroblast growth factor 2-transformed endothelial cells. 135
Antiangiogenic effectiveness of the urokinase receptor- derived peptide UPARANT in a model of oxygen-induced retinopathy 135
Long pentraxin-3 inhibits epithelial-mesenchymal transition in melanoma cells. 134
Distinct role of fibroblast growth factor-2 and vascular endothelial growth factor on tumor growth and angiogenesis. 132
Basic fibroblast growth factor-induced angiogenic phenotype in mouse endothelium. A study of aortic and microvascular endothelial cell lines. 132
A Pro-inflammatory Signature Mediates FGF2-induced Angiogenesis 132
Upregulation of urokinase-type plasminogen activator in squamous cell carcinoma of human larynx 131
ANGIOPOIETIN-1 MEDIATES THE PRO-ANGIOGENIC ACTIVITY OF THE BONE MORPHOGENIC PROTEIN ANTAGONIST DRM 129
3D endothelial cell spheroid/human vitreous humor assay for the characterization of anti-angiogenic inhibitors for the treatment of proliferative diabetic retinopathy 129
Subcellular localization and biological activity of a Mr 18,000 basic fibroblast growth factor: site directed mutagenesis of a putative nuclear translocation sequence 128
Stromal delivery of long Pentraxin-3 impairs FGF/FGFR-dependent tumor growth and metastasis 128
Heparin octasaccharides inhibit angiogenesis in vivo. 128
Nerve growth factor-endothelial cell interaction leads to angiogenesis in vitro and in vivo. 127
Ascorbic acid rescues cardiomyocyte development in Fgfr1(-/-) murine embryonic stem cells. 127
A distinct basic fibroblast growth factor (FGF-2/FGF receptor interaction distinguishes urokinase-type plasminogen activator induction from mitogenicity in endothelial cells 126
Long Pentraxin 3-Mediated Fibroblast Growth Factor Trapping Impairs Fibrosarcoma Growth 126
Chemical structure and genotoxic activity of the hepatocarcinogenic beta-blocker DL-ZAMI 1305. 125
Age-dependent, seasonal and daily variations of the DNA damaging capacity of the hepatocarcinogen ZAMI 1305 in female rat liver. 125
Ascorbic acid rescues cardiomyocyte development in Fgfr1-/- murineembryonic stem cells 125
Molecular cloning and knockdown of galactocerebrosidase in zebrafish: New insights into the pathogenesis of Krabbe's disease. 125
Inflammation and N-formyl peptide receptors mediate the angiogenic activity of human vitreous humour in proliferative diabetic retinopathy 125
Basic fibroblast growth factor requires a long-lasting activation of protein kinase C to induce cell proliferation in transformed fetal bovine aortic endothelial cells. 124
Dendritic cells in inflammatory angiogenesis and lymphangiogenesis 124
N-tert-butyloxycarbonyl-Phe-Leu-Phe-Leu-Phe (BOC2) inhibits the angiogenic activity of heparin-binding growth factors 123
Calcitonin receptor-like receptor guides arterial differentiation in zebrafish. 122
Delivering cytokines at tumor site: The immunocytokine-conjugated anti-EDB-fibronectin antibody case 122
Total reflection X-Ray fluorescence spectroscopy to study Pb and Zn accumulation in zebrafish embryos 122
A mutant of basic fibroblast growth factor that has lost the ability to stimulate plasminogen activator synthesis in endothelial cells. 122
Long-Pentraxin 3 Derivative as a Small-Molecule FGF Trap for Cancer Therapy 122
ANGIOPOIETIN-1 MEDIATES THE PRO-ANGIOGENIC ACTIVITY OF THE BONE-MORPHOGENIC PROTEIN ANTAGONIST DRM 121
Antiangiogenic and vascular-targeting activity of the microtubule-destabilizing trans-resveratrol derivative 3,5,4'-trimethoxystilbene. 120
Basic fibroblast growth factor in ovulatory cycle and postmenopausal human endometrium. 120
Role of Nanomechanics in Canonical and Noncanonical Pro-angiogenic Ligand/VEGF Receptor-2 Activation 120
Zebrafish (Danio rerio) embryo as a platform for the identification of novel angiogenesis inhibitors of retinal vascular diseases 120
d-Peptide analogues of Boc-Phe-Leu-Phe-Leu-Phe-COOH induce neovascularization via endothelial N-formyl peptide receptor 3 120
alphav/beta3 Integrin mediates the cell-adhesive capacity and biological activity of basic fibroblast growth factor (FGF2) in cultured endothelial cells 117
Biosafe inertization of municipal solid waste incinerator residues by COSMOS technology. 117
Human basic fibroblast growth factor: structure- function relationship of an angiogenic molecule 116
Examining new models for the study of autocrine and paracrine mechanisms of angiogenesis through FGF2-transfected endothelial and tumour cells. 116
Totale 16.809
Salva come PNG Salva come JPEG
Categoria #
all - tutte 158.463
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 158.463
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20206.379 0 0 0 0 0 1.174 1.128 1.067 781 1.235 455 539
2020/20216.021 181 641 232 709 324 618 262 687 758 527 702 380
2021/20223.039 176 664 62 78 41 137 191 182 150 430 232 696
2022/20232.386 417 113 114 138 178 627 17 188 315 37 112 130
2023/20242.949 186 98 337 117 124 466 123 127 680 127 58 506
2024/20252.245 86 57 40 861 652 549 0 0 0 0 0 0
Totale 35.644